E-drug: Withdrawal of products (Re: Adolexin posting)
----------------------------------------------------------
I could not agree more with Dr Gopal regarding the tactics of Multinational
Pharmaceutical Companies. Glaxo Wellcome cancelled their entire range of
cancer chemotherapeutic agents from the Zimbabwe market despite making
profits on other products. This is causing unnecessary supply constraints in
an environment with many other challenges.
G N Mahlangu (Ms)
mcaz@africaonline.co.zw
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.